trial · primary record
JNJ-95804306
Hematologic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 320 |
| Primary completion | 2032-09-24 |
| Primary endpoint | Part 1: Number of Participants with Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT07572006 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:14.693Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07572006
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.